Observational study assessing incidence of osteosarcoma among Forteo(teriparatide) users by linking state cancer registry data to large national pharmacy database data (B3D-MC-GHBX Addendum 2.3)

07/04/2017
01/04/2024
EU PAS number:
EUPAS18547
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

B3D-MC-GHBX Amendment (2.3)(b)

English (411.62 KB - PDF) View document
Study results
Study results

LY333334 B3D-MC-GHBX 2.3(b) Non-interventional PASS Full Clinical Study Report_Redacted

English (4.05 MB - PDF) View document
Study report
Other information